# Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

> **NCT06154590** · — · NOT_YET_RECRUITING · sponsor: **DR. DIANE CHISESI NFS. MD. PHD.** · enrollment: 100 (estimated)

## Conditions studied

- Metastatic Breast Cancer
- Tumor
- Muscle Neoplasms
- Chronic Pain

## Interventions

- **DRUG:** Method(s)1 Attribution
- **DRUG:** Method(s)2 Attribution,

## Key facts

- **NCT ID:** NCT06154590
- **Lead sponsor:** DR. DIANE CHISESI NFS. MD. PHD.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2025-08
- **Final completion:** 2026-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06154590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06154590, "Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06154590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*